Literature DB >> 25669831

Concomitant EGFR and KRAS mutations in ALK-rearranged lung cancer.

G Rossi1, L Baldi2, F Barbieri3, F Bertolini3, M Tiseo4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25669831     DOI： 10.1093/annonc/mdv067

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases.

Authors:  Giuseppe Lo Russo; Martina Imbimbo; Giulia Corrao; Claudia Proto; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Laura Botta; Nicoletta Zilembo; Filippo de Braud; Marina Chiara Garassino
Journal:  Oncotarget       Date:  2017-04-26

2.  Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma.

Authors:  Dhoha Dhieb; Imen Belguith; Laura Capelli; Elisa Chiadini; Matteo Canale; Sara Bravaccini; Ilhem Yangui; Ons Boudawara; Rachid Jlidi; Tahya Boudawara; Daniele Calistri; Leila Ammar Keskes; Paola Ulivi
Journal:  Cells       Date:  2019-05-28       Impact factor: 6.600

3.  Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.

Authors:  Rohan Gupta; Idoroenyi Amanam; Syed Rahmanuddin; Isa Mambetsariev; Yingyu Wang; Charity Huang; Karen Reckamp; Lalit Vora; Ravi Salgia
Journal:  Am J Clin Oncol       Date:  2019-04       Impact factor: 2.339

Review 4.  Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations.

Authors:  Giorgia Guaitoli; Federica Bertolini; Stefania Bettelli; Samantha Manfredini; Michela Maur; Lucia Trudu; Beatrice Aramini; Valentina Masciale; Giulia Grisendi; Massimo Dominici; Fausto Barbieri
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.